WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115414) ORALLY-ADMINISTRABLE COMPOSITIONS COMPRISING STABLE AMORPHOUS CALCIUM CARBONATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115414    International Application No.:    PCT/IL2005/000545
Publication Date: 08.12.2005 International Filing Date: 26.05.2005
IPC:
A61K 9/00 (2006.01), A61K 9/20 (2006.01), A61K 9/38 (2006.01), A23J 1/04 (2006.01)
Applicants: Ben-Gurion University of the Negev Research and Development Authority [IL/IL]; P.O.Box 653, 84105 Beer-Sheva (IL) (For All Designated States Except US).
SAGI, Amir [IL/IL]; (IL) (For US Only).
BERMAN, Amir [IL/IL]; (IL) (For US Only)
Inventors: SAGI, Amir; (IL).
BERMAN, Amir; (IL)
Agent: Pyernik Rutman; Beit Etzion, 91 Herzl St., P.O.Box 10012, 84106 Beer-Sheva (IL)
Priority Data:
60/574,208 26.05.2004 US
Title (EN) ORALLY-ADMINISTRABLE COMPOSITIONS COMPRISING STABLE AMORPHOUS CALCIUM CARBONATE
(FR) COMPOSITIONS ADMINISTRABLES PAR VOIE ORALE COMPRENANT DU CARBONATE DE CALCIUM AMORPHE STABLE
Abstract: front page image
(EN)The present invention provides orally-administrable compositions comprising stable amorphous calcium carbonate (ACC). The compositions are preferably prepared as solid dosage forms such as tablets, capsules and powders. The present invention further provides methods for supplementing oral calcium intake in subjects as well as methods for treating osteoporosis, osteomalacia and related diseases.
(FR)Cette invention concerne des compositions administrables par voie orale, qui comprennent du carbonate de calcium amorphe (ACC) stable. Ces compositions sont de préférence préparées sous la forme de doses solides, telles que comprimés, capsules et poudres. Cette invention concerne en outre des procédés servant à compléter l'absorption de calcium par voie orale chez des sujets, ainsi que des procédés pour traiter l'ostéoporose, l'ostéomalacie et des maladies apparentées.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)